Skip to main content
OpenTrials
Completed

NCT Number: NCT00315029

Patient-Centered Implementation Trial for Single Embryo Transfer

Background: The number of multiple pregnancies is considered to be the most important adverse effect of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). IVF or ICSI with transferring only one embryo, elective single embryo transfer (eSET), will reduce this incidence remarkably. Unfortunately, former research has documented that cycles with SET maintain lower pregnancy rates compared to double embryo transfer (DET). Implementation of eSET will require a carefully chosen and thoroughly defined implementation strategy focussed on the couple undergoing the subfertility treatment. This trial will investigate the (cost)effectiveness of a combined patient centred implementation strategy.

Objective: The main aim is to compare the effectiveness and costs of implementation of elective single embryo transfer (eSET) in in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), between usual care and a combined patient-centred strategy.

Study design: A randomised controlled trial

Study population: Couples with a female age less than 40 years ongoing an IVF/ICSI treatment in 2 of the 13 Dutch IVF centres and their 4 satellite/transport centres.

Intervention A combined patient centred implementation strategy for eSET in IVF/ICSI. The strategy consists of counselling through an evidence based decision aid and reimbursement of a 4th cycle if couples have chosen for eSET in the first 2 cycles.

Primary study parameters/outcome of the study: the eSET occurrence rate, pregnancy outcomes and cost-effectiveness of the combined strategy.

Secondary study parameters/outcome of the study:

* patient knowledge * patient decisional conflict * patient satisfaction * IVF/ICSI treatment outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–39 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Catharina ziekenhuis Eindhoven, Eindhoven, Netherlands

Loading trial locations.

About this study

see above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female age < 39 years
  • In first cycle minimum of two embryos available for transfer

Exclusion criteria

  • Medical necessity for single embryo transfer

Treatment and study plan

evidence based decision aid

Behavioral

evidence based decision aid

Possible reimbursement 4th IVF/ICSI cycle when necessary

Behavioral

Potential reimbursement 4th IVF/ICSI cycle when necessary

Primary outcomes

  1. Incidence choice for eSET

    Time frame: after embryo transfer

Secondary outcomes

  1. Patient knowledge

    Time frame: during treatment

  2. patient decisional conflict

    Time frame: during treatment

  3. Patient experiences

    Time frame: duringg treatment

  4. Pregnancy outcomes

    Time frame: after treatment

  5. Cost-effectiveness

    Time frame: after follow up

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

Registry information

Official study title

Patient-Centered Implementation of Elective Single Embryo Transfer (eSET) in in Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI)

Important dates

Study start
2006
Primary completion
2008
Study completion
2008
First posted
Apr 17, 2006
Registry last updated
Oct 27, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.